All news

Electronic submission offers benefits for pharma, says ISI

Electronic submission offers benefits for pharma, says ISI

By Gareth Macdonald

Drug firms continue to make basic errors in their electronic submissions according to French regulatory group the AFSSAPS, which said recently that it returns half the NeeS dossiers it receives as they do not meet basic validation standards.